How CNS researchers are handling clinical trial turbulence
The field of central nervous system (CNS) drug development is awash with activity. Data from GlobalData’s drugs database, as of …
Post
-
-
NICE green lights two blood cancer therapies for NHS use
Two blood cancer treatments will now be available on the UK’s National Health Service (NHS) following recommendations from the National …
-
Incyte and Genesis collaborate on small-molecule medicines
Incyte and Genesis Therapeutics have entered a strategic partnership aimed at the research, discovery and development of new small-molecule medicines. Incyte …
-
Navigating the Complexities of Sustainable Specialty Pharma Supply Chains
The pharmaceutical world is changing. Sales of personalised therapies, for example, will skyrocket from $8 billion in 2022 to a …
-
Japan’s MHLW approves CSL Behring’s Andembry to stop HAE attacks
CSL Behring KK has gained approval from Japan's Ministry of Health, Labour and Welfare (MHLW) to manufacture and market subcutaneous …
-
Japan’s MHLW approves CSL Behring’s Andembry to stop HAE attacks
CSL Behring KK has gained approval from Japan's Ministry of Health, Labour and Welfare (MHLW) to manufacture and market subcutaneous …
-
FibroGen sells China unit to AstraZeneca for $160m
AstraZeneca has agreed to acquire FibroGen’s China subsidiary for approximately $160m, securing full control over the anaemia drug roxadustat in …
-
Zealand Pharma steadfastly upholds amylin-based obesity drug strategy
Zealand Pharma’s search for a partner for its amylin-based obesity therapy petrelintide remains ongoing, with no agreement announced in its …
-
X4 and taiba to distribute WHIM syndrome therapy in Middle East
US-based X4 Pharmaceuticals has entered an exclusive agreement with United Arab Emirates (UAE)-based pharmaceutical products wholesaler taiba rare to distribute …
-
Key pharma launch trends in 2024
Drug manufacturers faced a variety of hurdles in 2024. Healthcare system reforms, preparation for the EU joint clinical assessments (JCAs) …
-
WHO targets over half a million children in Gaza for polio vaccine drive
The World Health Organization (WHO) said it will conduct another mass vaccination round in the Gaza Strip to protect children …
-
FDA authorises ImmunityBio’s BCG alternative to treat bladder cancer
ImmunityBio has gained US Food and Drug Administration (FDA) authorisation for an expanded access programme to supply an alternative source …
-
Pharma and medtech industry reacts to FDA, CDC and NIH job cuts
Figures from across the pharmaceutical and medtech industry have spoken out on social media following the culling of staff at …
-
FDA grants priority review for Boehringer’s zongertinib NDA in NSCLC
The US Food and Drug Administration (FDA) has granted priority review to Boehringer Ingelheim’s new drug application (NDA) for zongertinib …
-
Scientists develop largest ever biological AI model that ‘thinks in nucleotides’
A team of US scientists has developed a new foundation model that can sift through genetic code across biology's five …
